| Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up MG Mazza, M Palladini, R De Lorenzo, C Magnaghi, S Poletti, R Furlan, ... Brain, behavior, and immunity 94, 138-147, 2021 | 504 | 2021 |
| Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life S Poletti, M Palladini, MG Mazza, R De Lorenzo, R Furlan, F Ciceri, ... European archives of psychiatry and clinical neuroscience, 1-10, 2022 | 125 | 2022 |
| One-year mental health outcomes in a cohort of COVID-19 survivors MG Mazza, M Palladini, R De Lorenzo, B Bravi, S Poletti, R Furlan, ... Journal of psychiatric research 145, 118-124, 2022 | 102 | 2022 |
| Long-term effect of childhood trauma: Role of inflammation and white matter in mood disorders S Poletti, M Paolini, J Ernst, I Bollettini, E Melloni, B Vai, Y Harrington, ... Brain, Behavior, & Immunity-Health 26, 100529, 2022 | 15 | 2022 |
| Cognitive remediation therapy for post-acute persistent cognitive deficits in COVID-19 survivors: a proof-of-concept study M Palladini, B Bravi, F Colombo, E Caselani, C Di Pasquasio, G D’Orsi, ... Neuropsychological Rehabilitation 33 (7), 1207-1224, 2023 | 14 | 2023 |
| Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder F Benedetti, M Palladini, G D'Orsi, R Furlan, F Ciceri, P Rovere-Querini, ... Journal of affective disorders 308, 554-561, 2022 | 12 | 2022 |
| Choroid plexus volume is increased in mood disorders and associates with circulating inflammatory cytokines B Bravi, EMT Melloni, M Paolini, M Palladini, F Calesella, L Servidio, ... Brain, Behavior, and Immunity 116, 52-61, 2024 | 11 | 2024 |
| Antidepressant chronotherapeutics normalizes prefrontal 1H-MRS glutamate in bipolar depression EMT Melloni, B Bravi, S Poletti, S Dallaspezia, B Barbini, R Zanardi, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 119, 110606, 2022 | 11 | 2022 |
| Brain spectroscopic measures of glutamatergic and neuronal metabolism and glial activation influence white matter integrity in bipolar depression B Bravi, I Bollettini, C Di Pasquasio, A Falini, C Colombo, R Zanardi, ... Psychiatry Research: Neuroimaging 326, 111534, 2022 | 2 | 2022 |
| A machine learning pipeline for efficient differentiation between bipolar and major depressive disorder based on multimodal structural neuroimaging F Calesella, F Colombo, B Bravi, L Fortaner-Uyà, C Monopoli, S Poletti, ... Neuroscience Applied 3, 103931, 2024 | 1 | 2024 |
| Circulating inflammatory markers predict depressive symptomatology in COVID-19 survivors M Palladini, MG Mazza, R De Lorenzo, S Spadini, V Aggio, M Bessi, ... Cytokine 186, 156839, 2025 | | 2025 |
| Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and … F Colombo, F Calesella, B Bravi, L Fortaner-Uyà, C Monopoli, E Tassi, ... European Neuropsychopharmacology 85, 45-57, 2024 | | 2024 |
| Unveiling choroid plexus as biomarker for mood disorders: its role on white matter and cognitive deficits A Bertolotti, B Bravi, M Biondi, S Poletti, M Palladini, C Colombo, ... Neuroscience Applied 3, 2024 | | 2024 |
| Neurosubtypes of deeply phenotyped depressed patients reflect multivariate associations with childhood trauma and cognitive biases F Colombo, F Calesella, M Acconcia, T Cazzella, B Bravi, L Fortaner-Uyà, ... Neuroscience Applied 3, 104206, 2024 | | 2024 |
| The influence of schizophrenia-related genetic risk on glutamate dysregulation and illness trajectory in bipolar disorder: a potential basis for neuroprogression A Grifoni, M Paolini, B Bravi, L Raffaelli, L Fortaner-Uyà, C Colombo, ... Neuroscience Applied 3, 104970, 2024 | | 2024 |
| Investigating the neural correlates of treatment-resistance depression: a white matter integrity study C Milano, B Bravi, M Paolini, M Maccario, C Colombo, R Zanardi, ... Neuroscience Applied 3, 104936, 2024 | | 2024 |
| Choroid plexus volume is increased in treatment-resistant major depressive disorder B Bravi, M Paolini, M Maccario, C Milano, C Colombo, R Zanardi, ... Neuroscience Applied 3, 104664, 2024 | | 2024 |
| Kynurenic acid affects amplitude of functional spontaneous activity and cognition in bipolar disorder B Bravi, M Palladini, S Poletti, S Comai, C Colombo, R Zanardi, ... Neuroscience Applied 3, 104918, 2024 | | 2024 |
| Relation between childhood trauma, white matter microstructure and antidepressant treatment response in major depressive disorder: role of genetic liability. M Paolini, L Raffaelli, V Bettonagli, M Maccario, B Bravi, L Fortaner-Uyà, ... Neuroscience Applied 3, 104923, 2024 | | 2024 |
| The genetic landscape of kynurenine predicts neurovascular pathology and disrupted white matter integrity in patients with mood disorders. B Bravi, L Fortaner Uyá, M Paolini, S Comai, S Poletti, C Lorenzi, ... medRxiv, 2024.12. 11.24317786, 2024 | | 2024 |
